Paxman AB (publ) (PAX.ST) Research

Paxman AB (publ), along with its subsidiaries, specializes in the creation and worldwide sale of the Paxman scalp cooling system, an innovative solution designed to minimize hair loss in patients undergoing chemotherapy. This system is distributed across Europe, the United States, Mexico, Japan, Oceania, various Asian regions, and both South and Central America, primarily serving cancer centers and hospitals. The company is also engaged in a research collaboration agreement with the National University Hospital in Singapore, working towards the development of a portable cooling and compression device. Established in 1996, Paxman AB (publ) is headquartered in Karlshamn, Sweden.

Market snapshot

Symbol
PAX.ST
Price
$50.80
Day change
0.00%
Market cap
$1.2B
P/E ratio
-108.50x
52-week range
41-85
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • ADDvise Group AB (publ) (ADDV-B.ST)
  • BICO Group AB (publ) (BICO.ST)
  • C-Rad AB (publ) (CRAD-B.ST)
  • Diamyd Medical AB (publ) (DMYD-B.ST)
  • Genovis AB (publ.) (GENO.ST)
  • OssDsign AB (publ) (OSSD.ST)
  • Sedana Medical AB (publ) (SEDANA.ST)
  • Senzime AB (publ) (SEZI.ST)

Open Paxman AB (publ) (PAX.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.